You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Expanded natural killer cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Los Angeles (Haploidentical IL-21-Expanded Natural Killer Cells)

Enrolling by invitation
  • Acute Myeloid Leukemia
  • Haploidentical IL-21-Expanded Natural Killer Cells
  • Los Angeles, California
    Children's Hospital Los Angeles
Nov 1, 2021

Pediatric Brain Tumor, Recurrent Pediatric Brain Tumor, Pediatric Supratentorial Tumor Trial in San Francisco (Universal Donor

Not yet recruiting
  • Pediatric Brain Tumor
  • +2 more
  • Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells
  • Implantation
  • San Francisco, California
    University of California, San Francisco
May 24, 2023

Leukemia, Acute Myeloid, Leukemia, Acute Lymphoblastic Trial in Minsk (Expanded Haploidentical Natural Killer cells, IL-2)

Completed
  • Leukemia, Acute Myeloid
  • Leukemia, Acute Lymphoblastic
  • Expanded Haploidentical Natural Killer cells
  • IL-2
  • Minsk, Minsk Region, Belarus
    Belarussian Research Center for Pediatric Oncology, Hematology a
Feb 28, 2022

Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis (Nicotinamide Expanded Haploidentical

Completed
  • Multiple Myeloma
  • +7 more
  • Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute

Completed
  • Chronic Myeloid Leukemia (CML)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 31, 2022

Extranodal NK/T-cell Lymphoma Trial in Houston (sugemalimab)

Available
  • Extranodal NK/T-cell Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 18, 2022

Acute Myeloid Leukemia Trial in Minsk (NK cell infusions)

Recruiting
  • Acute Myeloid Leukemia
  • NK cell infusions
  • Minsk, Minsk Region, Belarus
    Belarussian Research Center for Pediatric Oncology, Hematology a
Feb 28, 2022

Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

Recruiting
  • Recurrent Adult T-Cell Leukemia/Lymphoma
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 18, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Columbus

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 28, 2022

Allogeneic Stem Cell Transplant Recipient, Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Recurrent Acute Myeloid

Recruiting
  • Allogeneic Stem Cell Transplant Recipient
  • +3 more
  • Cytarabine Hydrochloride
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 7, 2022

Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

Recruiting
  • Colorectal Cancer
  • +11 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 18, 2023

Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)

Recruiting
  • Relapsed Neuroblastoma
  • Refractory Neuroblastoma
  • Natural Killer Cells
  • +4 more
  • Columbus, Ohio
    Nationwide Children's Hospital
Oct 26, 2022

Mantle Cell Lymphoma, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Houston (procedure, drug, biological)

Completed
  • Mantle Cell Lymphoma
  • +6 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 18, 2022

Autologous Natural Killer Cell Activity in Primary Cancer Cell

Recruiting
  • Sarcoma
    • Santa Monica, California
      Sarcoma Oncology Research Center
    May 19, 2023

    Acute Myeloid Leukemia Trial in Columbus (Universal Donor Natural Killer Cells)

    Recruiting
    • Acute Myeloid Leukemia
    • Universal Donor Natural Killer Cells
    • Columbus, Ohio
      Nationwide Children's Hospital
    Aug 11, 2022

    Recurrent Childhood Medulloblastoma, Recurrent Ependymoma, Recurrent Medulloblastoma Trial in Houston (Laboratory Biomarker

    Completed
    • Recurrent Childhood Medulloblastoma
    • +2 more
    • Laboratory Biomarker Analysis
    • Natural Killer Cell Therapy
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 31, 2020

    Acute Myeloid Leukemia Trial in Minsk (Expanded haploidentical NK cells)

    Recruiting
    • Acute Myeloid Leukemia
    • Expanded haploidentical NK cells
    • Minsk, Minsk Region, Belarus
      Belarussian Research Center for Pediatric Oncology, Hematology a
    Apr 12, 2022

    Hepatocellular Carcinoma Trial in Jakarta Pusat (Autologous Natural Killer Cell Therapy, Clinimacs Plus)

    Recruiting
    • Hepatocellular Carcinoma
    • Autologous Natural Killer Cell Therapy
    • Clinimacs Plus
    • Jakarta Pusat, Jakarta, Indonesia
      Cipto Mangunkusumo General Hospital
    Sep 24, 2023

    Multiple Myeloma Trial in Stockholm (autologous NK cells)

    Unknown status
    • Multiple Myeloma
    • autologous NK cells
    • Stockholm, Sweden
      Karolinska University Hospital
    Feb 16, 2021

    Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Cytokine Induced Memory-like Natural Killer Cells
    • Interleukin-2
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2023

    Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (drug, biological, other)

    Completed
    • Recurrent Adult Acute Myeloid Leukemia
    • Refractory Acute Myeloid Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 18, 2021

    Multiple Myeloma Trial in United States (rhIL-2, PNK-007)

    Completed
    • Multiple Myeloma
    • Minneapolis, Minnesota
    • +6 more
    Jul 20, 2020

    Refractory Cancer, Metastatic Cancer, Recurrent Cancer Trial in Santa Monica (SNK01, Avelumab, Pembrolizumab)

    Active, not recruiting
    • Refractory Cancer
    • +6 more
    • SNK01
    • +2 more
    • Santa Monica, California
      Sarcoma Oncology Research Center
    Sep 25, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in Columbus (procedure, drug, biological)

    Not yet recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • HER2-Negative Breast Carcinoma
    • Biospecimen Collection
    • +5 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Aug 30, 2023

    Squamous Cell Carcinoma of Head and Neck, NSCLC, Colorectal Tumors Trial in Los Angeles (AFM24, SNK01)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +5 more
    • Los Angeles, California
      USC/Norris Comprehensive Cancer Center
    Jan 26, 2022